News about Global Pharma

Zydus's Chairman Pankaj R Patel Conferred with Padma Bhushan

With a Masters in Pharmaceutics and Pharmaceutical Technology from the L.M. College of Pharmacy and an alumni of the Indian Institute of Management (IIM), Ahmedabad, he was always driven by a passion to become a pharma entrepreneur.

Global Pharma | 27/01/2025 | By Aishwarya |  562

AstraZeneca To Invest CAD 820 Mn in Canada to Boost Clinical Delivery Sector

New investment in Canada will contribute to AstraZeneca’s global ambition to achieve USD80 billion in Total Revenue and to bring 20 new medicines to patients around the world by 2030 of which eight new medicines have been delivered to date.

Global Pharma | 27/01/2025 | By Aishwarya |  394

CStone Join Hands with SteinCares to Commercialize Sugemalimab in Latin America

As part of this collaboration, SteinCares will be responsible for the regulatory affairs and commercialization activities of sugemalimab in these regions.

Global Pharma | 27/01/2025 | By Aishwarya |  325

AbbVie Finalises Acquisition of Nimble Therapeutics

AbbVie has completed its acquisition of Nimble Therapeutics, adding Nimble's novel oral peptide IL23R inhibitor for psoriasis and proprietary peptide discovery platform to its immunology pipeline.

Global Pharma | 24/01/2025 | By Manvi |  393

Veeva and Zifo to Accelerate Quality Control Modernization

By bringing together Veeva LIMS with Zifo’s data integration and management platform, qcKen, companies can import data directly from any source document or other LIMS into Veeva LIMS.

Global Pharma | 24/01/2025 | By Aishwarya |  795

Medix Biochemica Announces Acquisition of CANDOR Bioscience

The acquisition both strengthens Medix Biochemica’s range of high-quality raw materials to the worldwide IVD industry and enhances its capabilities to support test manufacturers in immunoassay development.

Global Pharma | 24/01/2025 | By Aishwarya |  351

Piramal Critical Care Launches Chlorpromazine Hydrochloride for Injection, USP in US

Piramal Critical Care (PCC), a division of Piramal Pharma Ltd., has launched Chlorpromazine Hydrochloride for Injection, USP to be offered in 25mg/1mL and 50mg/2mL vials in the US, expanding its generic injectables portfolio.

Global Pharma | 23/01/2025 | By Manvi |  264

Zydus Announces USFDA Orphan Drug Designation to Usnoflast for Treatment of ALS

Zydus has received USFDA Orphan Drug Designation for Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS).

Global Pharma | 23/01/2025 | By Manvi |  300

Conduit and Agility to Develop Enhanced Formulations for its Autoimmune Pipeline

Conduit has developed a series of novel, advantageous solid forms of all its autoimmune pipeline assets, each protected by newly established composition-of-matter intellectual property (IP).

Global Pharma | 23/01/2025 | By Aishwarya |  489

Emcure Pharmaceuticals Launches its R&D Centre in Ahmedabad

The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies.

Global Pharma | 23/01/2025 | By Aishwarya |  928